Chen I-Chieh, Chiang Wei-Fan, Huang Hsin-Hsiu, Chen Pei-Fen, Shen Ying-Ying, Chiang Hung-Che
Division of Environmental Health and Occupational Medicine, National Health Research Institutes, Miaoli, Taiwan.
Mol Cancer. 2014 Nov 26;13:254. doi: 10.1186/1476-4598-13-254.
The epithelial-to-mesenchymal transition (EMT) process results in a loss of cell-cell adhesion, increased cell mobility, and is crucial for enabling the metastasis of cancer cells. Recently, the enzyme SIRT1 has been implicated in a variety of physiological processes; however, its role in regulating oral cancer metastasis and EMT is not fully elucidated. Here, we propose a mechanism by which the enzyme sirtuin1 (SIRT1) regulates the EMT process in oral cancer by deacetylating Smad4 and repressing the effect of TGF-β signaling on matrix metalloproteinase-7 (MMP7).
The roles of SIRT1 in tumor cell migration/invasion and metastasis to the lungs were investigated using the Boyden chamber assay and orthotopic injections, respectively. RNA interference was used to knockdown either SIRT1 or Smad4 expression in oral squamous cell carcinoma (OSCC) cell lines. Immunoblotting, zymographic assays, and co-immunoprecipitation were used to examine the effects of SIRT1 overexpression on MMP7 expression and activity, as well as on SIRT1/ Smad4 interaction.
We found that compared with normal human oral keratinocytes (HOKs), SIRT1 was underexpressed in OSCC cells, and also in oral cancer tissues obtained from 14 of 21 OSCC patients compared with expression in their matched normal tissues. Overexpression of SIRT1 inhibited migration of OSCC cells in vitro, as well as their metastasis to the lung in vivo. Furthermore, up-regulation of SIRT1 in metastatic OSCCs significantly inhibited the migration and invasion abilities of OSCC cells, while concomitantly increasing the expression of E-cadherin, and decreasing the expressions of mesenchymal markers. We also identified Smad4, a TGF-β-activated transcription factor, as a direct target protein for SIRT1. Overexpression of SIRT1 in OSCC cells led to decreased levels of acetylated Smad4, and inhibition of TGF-β-induced signaling. By associating and deacetylating Smad4, SIRT1 enzyme can influence MMP7 expression, MMP enzyme activity, and consequently, cell migration, invasion, and tumor metastasis in OSCCs.
These findings provide a valuable insight into the potential role of the SIRT1 enzyme in regulating cell migration and invasion in oral squamous cell carcinoma. Our findings suggest the SIRT1/Smad4/MMP7 pathway as a target for oral cancer driven by EMT.
上皮-间质转化(EMT)过程导致细胞间黏附丧失、细胞迁移能力增强,对癌细胞转移至关重要。最近,SIRT1酶参与了多种生理过程;然而,其在调节口腔癌转移和EMT中的作用尚未完全阐明。在此,我们提出一种机制,即沉默调节蛋白1(SIRT1)通过使Smad4去乙酰化并抑制转化生长因子-β(TGF-β)信号对基质金属蛋白酶-7(MMP7)的作用来调节口腔癌中的EMT过程。
分别使用Boyden小室实验和原位注射法研究SIRT1在肿瘤细胞迁移/侵袭及肺转移中的作用。采用RNA干扰技术敲低口腔鳞状细胞癌(OSCC)细胞系中SIRT1或Smad4的表达。使用免疫印迹法、酶谱分析和免疫共沉淀法检测SIRT1过表达对MMP7表达和活性以及SIRT1/Smad4相互作用的影响。
我们发现,与正常人口腔角质形成细胞(HOKs)相比,SIRT1在OSCC细胞中表达下调,并且在21例OSCC患者中的14例患者的口腔癌组织中与配对的正常组织相比表达也下调。SIRT1过表达抑制了OSCC细胞的体外迁移及其在体内的肺转移。此外,转移性OSCC中SIRT1的上调显著抑制了OSCC细胞的迁移和侵袭能力,同时增加了E-钙黏蛋白的表达,并降低了间充质标志物的表达。我们还确定了TGF-β激活的转录因子Smad4是SIRT1的直接靶蛋白。OSCC细胞中SIRT1的过表达导致乙酰化Smad4水平降低,并抑制了TGF-β诱导的信号传导。通过与Smad4结合并使其去乙酰化,SIRT1酶可影响MMP7表达、MMP酶活性,进而影响OSCC中的细胞迁移、侵袭和肿瘤转移。
这些发现为SIRT1酶在调节口腔鳞状细胞癌细胞迁移和侵袭中的潜在作用提供了有价值的见解。我们的研究结果表明,SIRT1/Smad4/MMP7途径是由EMT驱动的口腔癌的一个靶点。